The built environment is associated with infectious disease dynamics, particularly in diseases transmitted by contact, aerosols, or droplets.1,2 A recent study of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in New York revealed significant differences in hospitalization and death rates among the city’s boroughs, with the highest rates in Queens and the Bronx.3 To our knowledge, no studies have investigated associations between the built environment, markers of neighborhood socioeconomic status, and SARS-CoV-2 transmission. We leveraged a universal testing program for SARS-CoV-2 in pregnant women to examine associations between these factors and SARS-CoV-2 prevalence.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Alexander Melamed, MD, MPH, Division of Gynecologic Oncology, Vagelos College of Physicians and Surgeons, Columbia University, 161 Ft Washington Ave, New York, NY 10032 (email@example.com).
Published Online: June 18, 2020. doi:10.1001/jama.2020.11370
Author Contributions: Dr Melamed had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Emeruwa and Ona contributed equally.
Concept and design: Shaman, Turitz, Gyamfi-Bannerman, Melamed.
Acquisition, analysis, or interpretation of data: Emeruwa, Ona, Gyamfi-Bannerman, Wright, Melamed.
Drafting of the manuscript: Emeruwa, Ona, Melamed.
Critical revision of the manuscript for important intellectual content: Emeruwa, Ona, Shaman, Turitz, Gyamfi-Bannerman, Wright.
Statistical analysis: Melamed.
Administrative, technical, or material support: Shaman, Turitz, Gyamfi-Bannerman.
Supervision: Turitz, Melamed.
Conflict of Interest Disclosures: Dr Shaman and Columbia University reported partial ownership of SK Analytics. Dr Shaman reported receiving personal fees from Business Networking International and Merck. Dr Gyamfi-Bannerman reported receiving grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Heart, Lung, and Blood Institute, and AMAG/Society for Maternal-Fetal Medicine and receiving personal fees from Sera. Dr Wright reported receiving grants from Merck and receiving personal fees from Clovis Oncology. No other disclosures were reported.
Funding/Support: This study was supported by the National Center for Advancing Translational Sciences (KL2TR001874 [Dr Melamed]), the National Institute of General Medical Sciences (1U01GM110748 [Dr Shaman]), the National Science Foundation (DMS-2027369 [Dr Shaman]), National Heart, Lung, and Blood Institute (2R01HL098554 [Dr Gyamfi-Bannerman]), Eunice Kennedy Shriver National Institute of Child Health and Human Development (5UG1HD040485 [Dr Gyamfi-Bannerman]), the Society for Maternal-Fetal Medicine (Dr Gyamfi-Bannerman), and the Morris-Singer Foundation (Dr Shaman).
Role of the Funders/Sponsors: The funders/sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
You currently have no searches saved.
You currently have no courses saved.